To evaluate time‐related variations of neuroendocrine and immune system components (GH‐IGF1 axis, hypothalamus–pituitary–thyroid axis, melatonin, cortisol, lymphocyte subsets and IL2) in lung cancer patients compared to healthy controls. The gene discussed is IL2; the disease is lung carcinoma.